Should I buy or sell Boston Scientific stock right now?

21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 2 hold ratings, 18 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" BSX shares. View BSX analyst ratings or view top-rated stocks .

What is Boston Scientific's stock price target for 2024?

21 brokers have issued 1-year target prices for Boston Scientific's shares. Their BSX share price targets range from $60.00 to $90.00. On average, they expect the company's share price to reach $75.09 in the next year. This suggests a possible upside of 2.3% from the stock's current price. View analysts price targets for BSX or view top-rated stocks among Wall Street analysts .

How have BSX shares performed in 2024?

Boston Scientific's stock was trading at $57.81 at the beginning of 2024. Since then, BSX stock has increased by 27.0% and is now trading at $73.39. View the best growth stocks for 2024 here .

Are investors shorting Boston Scientific?

Boston Scientific saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 12,430,000 shares, an increase of 8.3% from the March 15th total of 11,480,000 shares. Based on an average daily volume of 6,410,000 shares, the short-interest ratio is presently 1.9 days. View Boston Scientific's Short Interest .

When is Boston Scientific's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024. View our BSX earnings forecast .

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) released its quarterly earnings data on Wednesday, January, 31st. The medical equipment provider reported $0.55 EPS for the quarter, topping the consensus estimate of $0.51 by $0.04. The medical equipment provider had revenue of $3.73 billion for the quarter, compared to the consensus estimate of $3.59 billion. Boston Scientific had a net margin of 12.06% and a trailing twelve-month return on equity of 16.63%. During the same period in the previous year, the business earned $0.45 earnings per share. Read the conference call transcript .

What ETFs hold Boston Scientific's stock?

ETFs with the largest weight of Boston Scientific (NYSE:BSX) stock in their portfolio include Fidelity Disruptive Medicine ETF (FMED) , Goldman Sachs Future Health Care Equity ETF (GDOC) , iShares U.S. Medical Devices ETF (IHI) , Global X Aging Population ETF (AGNG) , Simplify Health Care ETF (PINK) , BlackRock Future Health ETF (BMED) , IQ Healthy Hearts ETF (HART) and Tema Cardiovascular and Metabolics ETF (HRTS) .

What guidance has Boston Scientific issued on next quarter's earnings?

Boston Scientific updated its second quarter 2024 earnings guidance on Wednesday, April, 24th. The company provided EPS guidance of 0.570-0.590 for the period, compared to the consensus earnings per share estimate of 0.560. The company issued revenue guidance of $4.0 billion-$4.0 billion, compared to the consensus revenue estimate of $3.9 billion.

What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?

947 employees have rated Boston Scientific Chief Executive Officer Michael F. Mahoney on Glassdoor.com . Michael F. Mahoney has an approval rating of 98% among the company's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA) , Alibaba Group (BABA) , Intel (INTC) , AT&T (T) , CVS Health (CVS) , Walt Disney (DIS) , Bank of America (BAC) , Advanced Micro Devices (AMD) , Visa (V) and Salesforce (CRM) .

Who are Boston Scientific's major shareholders?

Boston Scientific's stock is owned by many different institutional and retail investors. Top institutional investors include Bank of New York Mellon Corp (1.05%), Sumitomo Mitsui Trust Holdings Inc. (0.25%), Assenagon Asset Management S.A. (0.21%), Congress Asset Management Co. MA (0.10%), New York State Teachers Retirement System (0.10%) and Allspring Global Investments Holdings LLC (0.08%). Insiders that own company stock include Arthur C Butcher , Charles J Dockendorff , Daniel J Brennan , David A Pierce , David S Wichmann , Edward F Mackey , Edward J Ludwig , Edward J Ludwig , Eric Francis Yves Thepaut , Ian T Meredith , Jeffrey B Mirviss, Jeffrey B Mirviss , Jodi Euerle Eddy , John Bradley Sorenson , Jonathan Monson , Joseph Michael Fitzgerald , Maulik Nanavaty , Meghan Scanlon , Michael F Mahoney, Michael F Mahoney , Nelda J Connors , Scott Olson , Vance R Brown , Wendy Carruthers and William F Bruss. View institutional ownership trends .

How do I buy shares of Boston Scientific?

Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Boston Scientific have any subsidiaries?

The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation. Read More

Top-Rated StocksTop-Rated Most-Upgraded StocksMost-Upgraded

NYSE:BSX

Boston Scientific (BSX) Stock Price, News & Analysis

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)

Free BSX Stock Alerts

$73.36

+0.10 (+0.14%)

(As of 01:22 PM ET)

Compare

Today's Range: $72.64
▼
$73.61
50-Day Range: $65.75
▼
$73.30
52-Week Range: $48.35
▼
$74.39

Volume: 4.16 million shs
Average Volume: 6.53 million shs
Market Capitalization: $107.63 billion

P/E Ratio: 61.65
Dividend Yield: N/A
Price Target: $74.27

Get Boston Scientific alerts:

Boston Scientific MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.95 Rating Score
Upside/Downside: 2.3% Upside
$75.09 Price Target
Short Interest: Healthy
0.90% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -1.02
Upright™ Environmental Score
News Sentiment: 0.62
Based on 62 Articles This Week
Insider Trading: Selling Shares
$3.42 M Sold Last Quarter
Proj. Earnings Growth: 9.48%
From $2.32 to $2.54 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.39 out of 5 stars

Medical Sector

115th out of 908 stocks

Surgical & Medical Instruments Industry

15th out of 97 stocks

2.5

Analyst's Opinion

Consensus Rating
Boston Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.95, and is based on 18 buy ratings, 2 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Boston Scientific has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
0.90% of the outstanding shares of Boston Scientific have been sold short.
Short Interest Ratio / Days to Cover
Boston Scientific has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Boston Scientific has recently increased by 5.87%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Boston Scientific does not currently pay a dividend.
Dividend Growth
Boston Scientific does not have a long track record of dividend growth.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Boston Scientific has received a 60.69% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Medical monitors for cardiac surgery", "Surgical instruments for cardiac operations", "Cardiac resynchronization therapy (CRT) devices", "Wound closure devices", "Medical endoscopes", and "Coronary stents" products. See details.
Environmental Sustainability
The Environmental Impact score for Boston Scientific is -1.02.

2.6

News and Social Media Coverage

News Sentiment
Boston Scientific has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.33 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 62 news articles for Boston Scientific this week, compared to 24 articles on an average week.
Search Interest
Only 21 people have searched for BSX on MarketBeat in the last 30 days. This is a decrease of -9% compared to the previous 30 days.
MarketBeat Follows
Only 24 people have added Boston Scientific to their MarketBeat watchlist in the last 30 days. This is a decrease of -14% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Boston Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,418,529.00 in company stock.
Percentage Held by Insiders
Only 0.50% of the stock of Boston Scientific is held by insiders.
Percentage Held by Institutions
89.07% of the stock of Boston Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Boston Scientific are expected to grow by 9.48% in the coming year, from $2.32 to $2.54 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Boston Scientific is 61.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 137.93.
Price to Earnings Ratio vs. Sector
The P/E ratio of Boston Scientific is 61.67, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 176.78.
Price to Earnings Growth Ratio
Boston Scientific has a PEG Ratio of 2.48. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Boston Scientific has a P/B Ratio of 5.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Priority Gold

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

About Boston Scientific Stock (NYSE:BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

BSX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BSX Stock News Headlines

April 3, 2024 | insidertrades.com

Insider Selling: Boston Scientific Co. (NYSE:BSX) EVP Sells 16,351 Shares of Stock

April 26, 2024 | americanbankingnews.com

Boston Scientific (NYSE:BSX) Hits New 12-Month High After Analyst Upgrade

April 26, 2024 | Priority Gold (Ad)

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

April 26, 2024 | americanbankingnews.com

Critical Comparison: Boston Scientific (NYSE:BSX) vs. InspireMD (NYSE:NSPR)

April 25, 2024 | msn.com

Upcoming Deadline to Share in Boston Scientific Corporation (BSX) Class Action Settlement

April 25, 2024 | msn.com

Emerson College anti-Israel agitators clash with Boston police; 4 officers injured, over 100 arrested

April 25, 2024 | markets.businessinsider.com

Boston Scientific: Strong Q1 Performance and Promising Future Drive Buy Rating

April 25, 2024 | finance.yahoo.com

Boston Scientific Corp (BSX) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and ...

April 26, 2024 | Priority Gold (Ad)

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

April 25, 2024 | americanbankingnews.com

Boston Scientific (NYSE:BSX) Price Target Increased to $82.00 by Analysts at Needham & Company LLC

April 25, 2024 | markets.businessinsider.com

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Boston Scientific (BSX) and CureVac (CVAC)

April 25, 2024 | markets.businessinsider.com

Boston Scientific Q1 Earnings and Revenues Top Estimates

April 25, 2024 | finance.yahoo.com

Q1 2024 Boston Scientific Corp Earnings Call

April 24, 2024 | markets.businessinsider.com

Buy Rating for Boston Scientific: Strong Q1 Performance and Promising Cardiology Pipeline Fuel Optimism

April 24, 2024 | msn.com

Boston Scientific hits 52-week high on Q1 beat

April 24, 2024 | msn.com

BSX Stock Earnings: Boston Scientific Beats EPS, Beats Revenue for Q1 2024

April 24, 2024 | finance.yahoo.com

Here’s Why Boston Scientific Corporation (BSX) Rose in Q1

April 24, 2024 | finance.yahoo.com

Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars

April 24, 2024 | finance.yahoo.com

The Bullish First-Quarter Report That Helped Boston Scientific Break Out — Twice

April 24, 2024 | investopedia.com

Boston Scientific Beats Forecasts, Boosts Outlook on Booming Heart Device Sales

April 24, 2024 | barrons.com

Boston Scientific Stock Rises on More Than Just an Earnings Beat

April 24, 2024 | seekingalpha.com

Boston Scientific Corporation 2024 Q1 - Results - Earnings Call Presentation

April 24, 2024 | marketwatch.com

Boston Scientific Lifts 2024 Outlook After Strong 1Q

April 24, 2024 | investing.com

Boston Scientific pipeline strength fuels quarterly earnings beat

April 24, 2024 | markets.businessinsider.com

Boston Scientific Boosts FY24 Outlook - Update

April 24, 2024 | markets.businessinsider.com

Boston Scientific Corp Q1 Profit Increases, beats estimates

April 24, 2024 | finance.yahoo.com

Boston Scientific Pops Into Buy Zones On Solid First-Quarter Report

See More Headlines

Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 1/31/2024
Today: 4/26/2024
Next Earnings (Estimated): 7/25/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Current Symbol: NYSE:BSX
CUSIP: 10113710
CIK: 885725
Web: www.bostonscientific.com
Phone: (508) 683-4000
Fax: 508-683-5675
Employees: 48,000
Year Founded: 1979

Price Target and Rating

Average Stock Price Target: $74.27
High Stock Price Target: $90.00
Low Stock Price Target: $60.00
Potential Upside/Downside: +1.3%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.95
Research Coverage: 21 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.19
Trailing P/E Ratio: 61.60
Forward P/E Ratio: 31.59
P/E Growth: 2.48
Net Income: $1.59 billion
Net Margins: 12.06%
Pretax Margin: 14.61%
Return on Equity: 16.63%
Return on Assets: 9.24%

Debt

Debt-to-Equity Ratio: 0.44
Current Ratio: 1.32
Quick Ratio: 0.82

Sales & Book Value

Annual Sales: $14.24 billion
Price / Sales: 7.55
Cash Flow: $2.92 per share
Price / Cash Flow: 25.11
Book Value: $13.33 per share
Price / Book: 5.50

Miscellaneous

Outstanding Shares: 1,467,100,000
Free Float: 1,459,761,000
Market Cap: $107.54 billion
Optionable: Optionable
Beta: 0.78

Social Links

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Michael F. Mahoney (Age 59)
Chairman, President & CEO
Comp: $4.83M
Mr. Daniel J. Brennan (Age 58)
Executive VP & CFO
Comp: $2.15M
Mr. Joseph M. Fitzgerald (Age 60)
Executive VP & Group President of Cardiology
Comp: $1.84M
Mr. Jeffrey B. Mirviss (Age 58)
Executive VP & President of Peripheral Interventions
Comp: $1.44M
Mr. Arthur Crosswell Butcher (Age 53)
Executive VP and Group President of MedSurg & Asia Pacific
Comp: $1.49M
Mr. David J. Roux (Age 67)
Independent Director
Comp: $135k
Mr. John Bradley Sorenson (Age 56)
Executive Vice President of Global Operations
Ms. Emily Woodworth (Age 46)
Senior VP, Global Controller & Chief Accounting Officer
Ms. Jodi Euerle Eddy (Age 50)
Senior VP and Chief Information & Digital Officer
Mr. Jonathan R Monson
Senior VP of Investor Relations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

Should I Buy Boston Scientific Stock? BSX Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Boston Scientific Co.:

Boston Scientific Corporation develops and markets medical devices for various medical specialties globally, providing a diversified product portfolio.
The company has shown consistent growth in revenue and profitability over recent periods, indicating a strong financial performance.
Recent insider selling activities, such as EVP John Bradley Sorenson selling shares, could indicate confidence in the company's future prospects.
Boston Scientific's focus on innovation and research in developing advanced medical devices keeps it competitive in the healthcare industry.
The current stock price of Boston Scientific Co. is relatively stable, offering potential for long-term investment growth.

Cons

Investors should be bearish about investing in Boston Scientific Co. for these reasons:

The medical device industry is subject to regulatory challenges and changes, which could impact Boston Scientific's operations and financial performance.
Market competition in the medical devices sector is intense, leading to potential pricing pressures and reduced market share for Boston Scientific.
Fluctuations in healthcare policies and reimbursement rates could affect the demand for Boston Scientific's products and services.
Investing in healthcare companies like Boston Scientific Co. carries inherent risks related to product recalls, lawsuits, and regulatory compliance issues.
Economic uncertainties and global health crises may impact the overall demand for medical devices, affecting Boston Scientific's revenue and growth prospects.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Boston Scientific pros and cons to contact@marketbeat.com.

BSX Stock Analysis - Frequently Asked Questions

Should I buy or sell Boston Scientific stock right now?: 21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 2 hold ratings, 18 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" BSX shares.
View BSX analyst ratings or view top-rated stocks.
What is Boston Scientific's stock price target for 2024?: 21 brokers have issued 1-year target prices for Boston Scientific's shares. Their BSX share price targets range from $60.00 to $90.00. On average, they expect the company's share price to reach $75.09 in the next year. This suggests a possible upside of 2.3% from the stock's current price.
View analysts price targets for BSX or view top-rated stocks among Wall Street analysts.
How have BSX shares performed in 2024?: Boston Scientific's stock was trading at $57.81 at the beginning of 2024. Since then, BSX stock has increased by 27.0% and is now trading at $73.39.
View the best growth stocks for 2024 here.
Are investors shorting Boston Scientific?: Boston Scientific saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 12,430,000 shares, an increase of 8.3% from the March 15th total of 11,480,000 shares. Based on an average daily volume of 6,410,000 shares, the short-interest ratio is presently 1.9 days.
View Boston Scientific's Short Interest.
When is Boston Scientific's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024.
View our BSX earnings forecast.
How were Boston Scientific's earnings last quarter?: Boston Scientific Co. (NYSE:BSX) released its quarterly earnings data on Wednesday, January, 31st. The medical equipment provider reported $0.55 EPS for the quarter, topping the consensus estimate of $0.51 by $0.04. The medical equipment provider had revenue of $3.73 billion for the quarter, compared to the consensus estimate of $3.59 billion. Boston Scientific had a net margin of 12.06% and a trailing twelve-month return on equity of 16.63%. During the same period in the previous year, the business earned $0.45 earnings per share.
Read the conference call transcript.
What ETFs hold Boston Scientific's stock?: ETFs with the largest weight of Boston Scientific (NYSE:BSX) stock in their portfolio include Fidelity Disruptive Medicine ETF (FMED), Goldman Sachs Future Health Care Equity ETF (GDOC), iShares U.S. Medical Devices ETF (IHI), Global X Aging Population ETF (AGNG), Simplify Health Care ETF (PINK), BlackRock Future Health ETF (BMED), IQ Healthy Hearts ETF (HART) and Tema Cardiovascular and Metabolics ETF (HRTS).

What guidance has Boston Scientific issued on next quarter's earnings?: Boston Scientific updated its second quarter 2024 earnings guidance on Wednesday, April, 24th. The company provided EPS guidance of 0.570-0.590 for the period, compared to the consensus earnings per share estimate of 0.560. The company issued revenue guidance of $4.0 billion-$4.0 billion, compared to the consensus revenue estimate of $3.9 billion.
What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?: 947 employees have rated Boston Scientific Chief Executive Officer Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among the company's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Boston Scientific own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and Salesforce (CRM).
Who are Boston Scientific's major shareholders?: Boston Scientific's stock is owned by many different institutional and retail investors. Top institutional investors include Bank of New York Mellon Corp (1.05%), Sumitomo Mitsui Trust Holdings Inc. (0.25%), Assenagon Asset Management S.A. (0.21%), Congress Asset Management Co. MA (0.10%), New York State Teachers Retirement System (0.10%) and Allspring Global Investments Holdings LLC (0.08%). Insiders that own company stock include Arthur C Butcher, Charles J Dockendorff, Daniel J Brennan, David A Pierce, David S Wichmann, Edward F Mackey, Edward J Ludwig, Edward J Ludwig, Eric Francis Yves Thepaut, Ian T Meredith, Jeffrey B Mirviss, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Jonathan Monson, Joseph Michael Fitzgerald, Maulik Nanavaty, Meghan Scanlon, Michael F Mahoney, Michael F Mahoney, Nelda J Connors, Scott Olson, Vance R Brown, Wendy Carruthers and William F Bruss.
View institutional ownership trends.
How do I buy shares of Boston Scientific?: Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Boston Scientific have any subsidiaries?: The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.
Read More

This page (NYSE:BSX) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Boston Scientific (BSX) Stock Price, News & Analysis

Boston Scientific MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Boston Scientific Stock (NYSE:BSX)

BSX Stock Price History

BSX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

Should I Buy Boston Scientific Stock? BSX Pros and Cons Explained

Pros

Cons

BSX Stock Analysis - Frequently Asked Questions

Overall MarketRank^™